The European Commission, European Medicines Agency (EMA) and the Brazilian Health Regulatory Agency (ANVISA) have a confidentiality arrangement in place since 2021, allowing the exchange of confidential information as part of their regulatory and scientific processes.

    Confidentiality arrangement

    The European Commission, EMA and ANVISA signed a confidentiality arrangement in 2021. It is valid for an indefinite period of time, unless terminated by either party:

      The confidential information that EMA and ANVISA can share includes:

      How useful was this page?

      Add your rating